Calidi BiotherapeuticsCLDI
13F holders, Q2 2025 (June 30)35holders −1
5new positions
6sold out
1famous investor
$0.23avg. 13F price*
At the end of Q2 2025, 35 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, down 1 from Q1 2025. 5 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($182K), Bank of Montreal ($97K) and Vanguard Group Inc. ($81K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $37K |
| Exits | 6 | $84K |
All 13F filers, Q1 2025 → Q2 2025: 215,759 shares bought and 2,818,985 shares sold, net −2,603,226 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Armistice Capital, LLC | 0.01% | Reduce -76.2% | 792,000 | $182K |
| Bank of Montreal | 0.00% | Reduce -13.7% | 422,500 | $97K |
| Vanguard Group Inc. | 0.00% | No change | 353,380 | $81K |
| Belpointe Asset Management LLC | 0.00% | No change | 249,833 | $57K |
| Geode Capital Management, LLC | 0.00% | Reduce -7.7% | 232,576 | $53K |
| HighTower Advisors, LLC | 0.00% | No change | 119,471 | $27K |
| CPR Investments Inc. | 0.02% | No change | 101,000 | $23K |
| Red Wave Investments LLC | 0.01% | No change | 80,828 | $19K |
| Citadel Advisors | 0.00% | New | 71,196 | $16K |
| State Street Corp. | 0.00% | No change | 61,290 | $14K |
| Northern Trust Corp. | 0.00% | No change | 48,693 | $11K |
| Drive Wealth Management, LLC | 0.00% | Reduce -18.2% | 45,000 | $10K |
| UBS Group AG | 0.00% | Add +4490100.0% | 44,902 | $10K |
| HRT Financial LP | 0.00% | New | 43,609 | $10K |
| Raymond James Financial Inc. | 0.00% | New | 31,100 | $7K |
| Osaic Holdings, Inc. | 0.00% | Add +39.0% | 26,753 | $6K |
| Delta Investment Management, LLC | 0.00% | No change | 21,023 | $5K |
| Goldman Sachs Group Inc. | 0.00% | New | 13,205 | $3K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 13,500 | $3K |
| Highbridge Capital Management LLC | 0.00% | No change | 12,501 | $3K |
| Finepoint Capital LP | 0.00% | No change | 12,499 | $3K |
| Avidian Wealth Enterprises, LLC | 0.00% | No change | 10,000 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +74.7% | 8,937 | $2K |
| Grassi Investment Management | 0.00% | No change | 10,000 | $2K |
| Virtu Financial LLC | 0.00% | Reduce -81.3% | 10,240 | $2K |
| Evermay Wealth Management LLC | 0.00% | No change | 6,342 | $1K |
| Royal Bank of Canada | 0.00% | No change | 5,000 | $1K |
| Barrett & Company, Inc. | 0.00% | No change | 3,500 | $805 |
| Morgan Stanley | 0.00% | Reduce -5.0% | 1,919 | $441 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 1,000 | $230 |
| SBI Securities Co., Ltd. | 0.00% | Add +86.7% | 560 | $129 |
| CVA Family Office, LLC | 0.00% | No change | 500 | $115 |
| Bank of America Corp. | 0.00% | Add +46.9% | 326 | $75 |
| BlackRock, Inc. | 0.00% | No change | 259 | $60 |
| JPMorgan Chase & Co. | 0.00% | New | 63 | $14 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.